Source:http://linkedlifedata.com/resource/pubmed/id/19623654
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-7-27
|
pubmed:abstractText |
Quantitative detection of minimal residual disease has prognostic value for some leukemias. Acute promyelocytic leukemia (APL) is characterized by the specific PML-RARalpha fusion gene from t(15;17). Added to three PML-RARalpha isoforms, alternative spliced forms of PML exons give rise to multiple isoforms even within a single patient. To date, multiple primer pairs for the detection of the various PML-RARalpha transcripts have been designed, potentially generating some nonspecific amplification products. Here, we established a real-time quantitative PCR (RQ-PCR) strategy with a single primer pair using LightCycler (sp-RQ-PCR), which could simultaneously detect three isoforms with equal specificity and sensitivity as well as alternative spliced forms. Results obtained with sp-RQ-PCR for 39 samples from 15 APL patients and 31 non-APL samples were compared with those with TaqMan assay with three primer pairs. In two of the APL samples, PML-RARalpha was detected in the TM, but not in the sp-RQ-PCR or nested PCR. Furthermore, the sp-RQ-PCR showed no positive results for the 31 non-APL samples, whereas the TM identified 13% (4/31) as positive. Electrophoresis detected some artifacts in the TM, which do not correspond to PML-RARalpha. We conclude that our sp-RQ-PCR is specific enough to identify various forms of PML-RARalpha and yields no false-positive results.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Fusion,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Isoforms,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Retinoic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/promyelocytic leukemia-retinoic...
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1098-2825
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
223-30
|
pubmed:meshHeading |
pubmed-meshheading:19623654-Bone Marrow Cells,
pubmed-meshheading:19623654-Cell Line, Tumor,
pubmed-meshheading:19623654-DNA Primers,
pubmed-meshheading:19623654-Humans,
pubmed-meshheading:19623654-Leukemia, Promyelocytic, Acute,
pubmed-meshheading:19623654-Oncogene Proteins, Fusion,
pubmed-meshheading:19623654-Prognosis,
pubmed-meshheading:19623654-Protein Isoforms,
pubmed-meshheading:19623654-RNA, Neoplasm,
pubmed-meshheading:19623654-Receptors, Retinoic Acid,
pubmed-meshheading:19623654-Reproducibility of Results,
pubmed-meshheading:19623654-Reverse Transcriptase Polymerase Chain Reaction
|
pubmed:year |
2009
|
pubmed:articleTitle |
Quantitative detection of PML-RARalpha fusion transcript by real-time PCR with a single primer pair.
|
pubmed:affiliation |
Faculty of Pharmacological Science, Himeji Dokkyo University, Himeji, Hyogo 670-8524, Japan. tmariko@himeji-du.ac.jp
|
pubmed:publicationType |
Journal Article,
Comparative Study
|